In the last trading session, 8.19 million shares of the CervoMed Inc (NASDAQ:CRVO) were traded, and its beta was 1.61. Most recently the company’s share price was $2.16, and it changed around -$8.09 or -78.93% from the last close, which brings the market valuation of the company to $17.83M. CRVO currently trades at a discount to its 52-week high of $26.38, offering almost -1121.3% off that amount. The share price’s 52-week low was $5.85, which indicates that the current value has fallen by an impressive -170.83% since then. We note from CervoMed Inc’s average daily trading volume that its 10-day average is 0.32 million shares, with the 3-month average coming to 123.29K.
CervoMed Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 3 recommended CRVO as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. CervoMed Inc is expected to report earnings per share of -0.58 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CervoMed Inc (NASDAQ:CRVO) trade information
Instantly CRVO has showed a red trend with a performance of -78.93% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 14.40 on recent trading dayincreased the stock’s daily price by 85.0%. The company’s shares are currently down -71.69% year-to-date, but still down -79.19% over the last five days. On the other hand, CervoMed Inc (NASDAQ:CRVO) is -82.78% down in the 30-day period. We can see from the shorts that 1.67 million shares have been sold at a short interest cover period of 22.04 day(s).
The consensus price target as assigned by Wall Street analysts is $16.32, which translates to bulls needing to increase their stock price by 86.76% from its current value. Analyst projections state that CRVO is forecast to be at a low of $16.32 and a high of $16.32.
CervoMed Inc (CRVO) estimates and forecasts
CervoMed Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -89.10 percent over the past six months and at a -115.85% annual growth rate that is well below the industry average of 17.10%. The year-over-year growth rate is expected to be 28.39%, up from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 1.92M in revenue for the current quarter. 3 analysts expect CervoMed Inc to make 1.58M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 2.49M and 2.35M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -22.96%. Forecasts for the next quarter put sales growth at -32.55%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 73.43%.
CRVO Dividends
CervoMed Inc’s next quarterly earnings report is expected to be released in January.
